These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28458352)

  • 1. Preparation of an Ultrafine Rebamipide Ophthalmic Suspension with High Transparency.
    Matsuda T; Hiraoka S; Urashima H; Ogura A; Ishida T
    Biol Pharm Bull; 2017; 40(5):665-674. PubMed ID: 28458352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model.
    Urashima H; Okamoto T; Takeji Y; Shinohara H; Fujisawa S
    Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K; Matsumiya W; Otsuka K; Maeda Y; Nagai T; Nakamura M
    BMC Ophthalmol; 2015 Jun; 15():58. PubMed ID: 26048396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation.
    Mimura M; Ueki M; Oku H; Sato B; Ikeda T
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):385-9. PubMed ID: 26483146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface.
    Hori Y; Kageyama T; Sakamoto A; Shiba T; Nakamura M; Maeno T
    J Ocul Pharmacol Ther; 2017; 33(6):493-497. PubMed ID: 28346860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits.
    Urashima H; Takeji Y; Okamoto T; Fujisawa S; Shinohara H
    J Ocul Pharmacol Ther; 2012 Jun; 28(3):264-70. PubMed ID: 22304618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.
    Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H
    Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse.
    Ogawa M; Simsek C; Kojima T; Nagata T; Igarashi A; Kawakita T; Dogru M; Shimazaki J; Tsubota K
    Eye Contact Lens; 2019 Mar; 45(2):93-98. PubMed ID: 30365413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
    Kinoshita S; Awamura S; Nakamichi N; Suzuki H; Oshiden K; Yokoi N;
    Am J Ophthalmol; 2014 Mar; 157(3):576-83.e1. PubMed ID: 24246575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery.
    Igarashi A; Kamiya K; Kobashi H; Shimizu K
    Cornea; 2015 Aug; 34(8):895-900. PubMed ID: 26020821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing.
    Nagai N; Ito Y; Okamoto N; Shimomura Y
    Exp Eye Res; 2016 Oct; 151():47-53. PubMed ID: 27423550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide protects against glaucoma eyedrop-induced ocular surface disorders in rabbits.
    Kawaguchi I; Kobayashi A; Higashide T; Takeji Y; Sakurai K; Kawaguchi C; Sugiyama K
    PLoS One; 2017; 12(10):e0186714. PubMed ID: 29049370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
    Cho HY; Yoon H; Park GK; Lee YB
    Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rebamipide ophthalmic suspension on optical quality in the short break-up time type of dry eye.
    Koh S; Inoue Y; Sugmimoto T; Maeda N; Nishida K
    Cornea; 2013 Sep; 32(9):1219-23. PubMed ID: 23676786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty.
    Kobashi H; Kamiya K; Shimizu K
    J Ocul Pharmacol Ther; 2017; 33(1):13-18. PubMed ID: 27937084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy.
    Tung NT; Park CW; Oh TO; Kim JY; Ha JM; Rhee YS; Park ES
    J Pharm Pharmacol; 2011 Dec; 63(12):1539-47. PubMed ID: 22060284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.
    Shoji J; Inada N; Tomioka A; Yamagami S
    PLoS One; 2020; 15(11):e0242617. PubMed ID: 33232357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.